Personal profile
About
Professor Herder teaches primarily in the Faculty of Medicine, across the undergraduate and postgraduate curriculums, on a variety of health law topics, including informed consent, patient-physician confidentiality, and regulation of the medical profession. Prior to arriving at Dalhousie, he taught in the areas of bioethics and intellectual property law at Loyola University Chicago’s School of Law.
Professor Herder’s research interests cluster around biomedical innovation policy, with particular focus on intellectual property law and practices connected to the commercialization of scientific research. As part of a three-year research project funded by the Canadian Institutes of Health Research, Professor Herder (Principal Investigator) and a team of interdisciplinary researchers are currently collecting empirical evidence about the inter-relationships between commercialization laws, policies, and practices and emerging health researchers. The team will use the collected empirical evidence to explore a series of normative questions about the ongoing commercialization of academic science.
Contact Information
Schulich School of Law
Weldon Law Building
6061 University Avenue
PO Box 15000
Halifax, Nova Scotia B3H 4R2
Related documents
Education/Academic qualification
LLB, Dalhousie University Schulich School of Law
LLM, Dalhousie University Schulich School of Law
BSc, Memorial University of Newfoundland
JSM, Stanford University
Research Interests
- Law and Technology
- Health Care Policy
- Law and Society
- Patent Law
- Intellectual Property Rights
- Health Care Regulation
- Pharmaceutical Law and Policy
Disciplines
- Law
- Medicine and Health Sciences
- Food and Drug Law
- Intellectual Property Law
- Health Law and Policy
- Pharmacy Administration, Policy and Regulation
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities -
SDG 11 Sustainable Cities and Communities -
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics where Matthew Herder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Aducanumab, Accelerated Approvals & the Agency: Why the FDA Needs Structural Reform
Herder, M., Jan. 1 2024, In: Journal of Law, Medicine and Ethics. 51, 4Research output: Contribution to journal › Article › peer-review
Open AccessFile -
'More of the Same, But Worse Than Before': A Qualitative Study of the Challenges Encountered by People Who Use Drugs in Nova Scotia, Canada During COVID-19
Wildeman, S., Herder, M., Comeau, E. & Bonn, M., Jan. 1 2023, In: PLoS ONE. 18, 1Research output: Contribution to journal › Article › peer-review
Open AccessFile -
‘A Most Equitable Drug’: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development
Herder, M., Grundy, Q., Campbell, C., Ali, R. & Holloway, K., Jan. 1 2023, In: Journal of Law, Medicine and Ethics. 52, 1, p. 80-97Research output: Contribution to journal › Article › peer-review
Open AccessFile -
A South African Company Addresses Vaccine Supply Inequity, Despite Canada’s Lack of Support
Herder, M. & Gold, E. R., Jan. 1 2022Research output: Other contribution
-
Authors' Response - A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global Health
Herder, M., Gold, E. R. & Murthy, S., Jan. 1 2022, In: Healthcare Policy. 17, 4, p. 45-47Research output: Contribution to journal › Article › peer-review